Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rinat Neuroscience Corp.

Division of Pfizer Inc.

Latest From Rinat Neuroscience Corp.

Finance Watch: Gossamer, Alector And Harpoon Launch First Biopharma IPOs Of 2019

Public Company Edition: Grossing $276m, Gossamer would have been the third-largest biopharma IPO in the US if it had launched last year. Also, recent public company financings include debt and follow-on offerings; and two more firms cut jobs – Capricor and Seres.

Financing Business Strategies

Teva's CGRP Inhibitor Fails In Chronic Cluster Headaches, Continues In Episodic

Unlike the migraine space, there is only one competitor for Teva's CGRP inhibitor in cluster headaches, but that opportunity narrowed with fremanezumab's failure in chronic cluster headaches, though a trial in episodic cluster headaches is ongoing.

Research and Development Strategies Neurology

Antibody Approach To CGRP Offers Safer Mode For Migraine Prevention, Labrys Says

Labrys is ready to advance a monoclonal antibody to Phase II for prevention of chronic migraine, after releasing pooled safety from five Phase I trials conducted by Pfizer.

BioPharmaceutical United States

SV and Polaris Back Gerngross' New Antibody Play

Adimab is the latest venture in the resurgent large-molecule platform space. The company is founded by yeast platform pioneers Tillman Gerngross (Glycofi, Dartmouth) and Dane Wittrup (BioDisplay, MIT). The company's Series A pulled in $6.2 million from lead backers SV Life Sciences and Polaris Venture Partners.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • Ronald Eastman, CEO
    Arnon Rosenthal, PhD, Pres. & CSO
    David W Pritchard, CBO
  • Contact Info
  • Rinat Neuroscience Corp.
    Phone: (650) 813-9250
    3155 Porter Dr.
    Palo Alto, CA 94304